Research progress of natural products and their derivatives against Alzheimer’s disease
Author:
Affiliation:
1. Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Pharmacy, Yanbian University, Yanji, Jilin, China
2. Center of Medical Functional Experiment, Yanbian University College of Medicine, Yanji, China
Funder
Higher Education Discipline Innovation Project
National Natural Science Foundation of China
Natural Science Research Foundation of Jilin Province for Sciences and Technology
Education Department Project of Jilin
Doctoral Research Start-up Fundation of Yanbian University
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14756366.2023.2171026
Reference100 articles.
1. Rational Design of Quinoxalinone-Based Red-Emitting Probes for High-Affinity and Long-Term Visualizing Amyloid-β In Vivo
2. DSNN: A DenseNet-Based SNN for Explainable Brain Disease Classification
3. Noopept efficiency in experimental Alzheimer disease (cognitive deficiency caused by β-amyloid25–35 injection into Meynert basal nuclei of rats)
4. Cholinergic receptor binding in unimpaired older adults, mild cognitive impairment, and Alzheimer’s disease dementia
5. Detection of a Novel Intraneuronal Pool of Insoluble Amyloid β Protein that Accumulates with Time in Culture
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Roles of natural products on myokine expression and secretion in skeletal muscle atrophy;General and Comparative Endocrinology;2024-09
2. Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's disease;European Journal of Medicinal Chemistry Reports;2024-08
3. Protective signature of xanthohumol on cognitive function of APP/PS1 mice: a urine metabolomics approach by age;Frontiers in Pharmacology;2024-07-24
4. Computational Insight of Oleracone L, Portulacatone B, and Portulacatal from Portulaca oleracea L. as Potential Anticholinesterase Inhibitors for Alzheimer’s;Processes;2024-07-12
5. Harnessing the Therapeutic Potential of Peptides for Synergistic Treatment of Alzheimer’s Disease by Targeting Aβ Aggregation, Metal-Mediated Aβ Aggregation, Cholinesterase, Tau Degradation, and Oxidative Stress;ACS Chemical Neuroscience;2024-07-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3